Not every stock needs a flashy growth story to outperform. Sometimes, the biggest winners are the companies that simply keep executing, quarter after quarter, year after year- it’s all about consistency. In 2025, a handful of quiet standouts are doing precisely that, delivering substantial year-to-date gains while continuing to reward investors with reliable income. These are businesses with deep moats, disciplined management teams, and a proven ability to thrive across market cycles. More News from Bar ...

Core Insights - U.S. stock futures are trading mixed, with several companies expected to report earnings that may attract investor attention [1] Company Summaries - **Conagra Brands Inc. (NYSE:CAG)**: Expected to report quarterly earnings of 44 cents per share on revenue of $2.99 billion. Shares gained 0.3% to $17.85 in after-hours trading [1] - **Nike Inc. (NYSE:NKE)**: Reported second-quarter revenue of $12.43 billion, exceeding analyst estimates of $12.22 billion. Earnings were 53 cents per share, beating estimates of 38 cents. However, gross margins declined for the second consecutive quarter, leading to a 10.8% drop in shares to $58.57 in after-hours trading [1] - **Paychex Inc. (NASDAQ:PAYX)**: Analysts expect quarterly earnings of $1.23 per share on revenue of $1.57 billion. Shares fell 0.5% to $113.69 in after-hours trading [1] - **FedEx Corp. (NYSE:FDX)**: Reported strong financial results for Q2 of fiscal 2026 and raised FY2026 guidance, now expecting revenue growth of 5% to 6%. The company reaffirmed plans for $1 billion in permanent cost reductions. Shares rose 0.1% to $287.50 in after-hours trading [1] - **Carnival Corp. (NYSE:CCL)**: Expected to post quarterly earnings of 25 cents per share on revenue of $6.37 billion. Shares rose 0.5% to $28.49 in after-hours trading [1]

Conagra Brands, Inc. (NYSE:CAG) will release earnings results for its second quarter before the opening bell on Friday, Dec. 19.Analysts expect the Chicago, Illinois-based company to report quarterly earnings at 44 cents per share, down from 70 cents per share in the year-ago period. The consensus estimate for Conagra Brands' quarterly revenue is $2.98 billion. Last year, it reported $3.2 billion in revenue, according to Benzinga Pro.On Oct. 1, Conagra Brands posted first-quarter fiscal 2026 results that to ...

Core Insights - Conagra Brands, Inc. is set to release its second-quarter earnings results on December 19, with analysts expecting earnings of 44 cents per share, a decline from 70 cents per share in the same quarter last year [1] - The consensus estimate for quarterly revenue is $2.98 billion, down from $3.2 billion reported in the previous year [1][2] Earnings Performance - In the first quarter of fiscal 2026, Conagra Brands exceeded Wall Street expectations but still reported year-over-year declines [2] - The company's shares fell by 0.7%, closing at $17.80 [2] Analyst Ratings and Price Targets - Wells Fargo analyst Chris Carey maintained an Equal-Weight rating and reduced the price target from $20 to $19 [3] - Stifel analyst Matthew Smith also maintained a Hold rating, cutting the price target from $21 to $19 [3] - Goldman Sachs analyst Leah Jordan maintained a Sell rating, lowering the price target from $18 to $16 [3] - Evercore ISI Group analyst David Palmer kept an In-Line rating, reducing the price target from $24 to $23 [3] - Morgan Stanley analyst Megan Alexander maintained an Equal-Weight rating and raised the price target from $20 to $21 [3]

Core Insights - CreateAI's upcoming open-world RPG, Heroes of Jin Yong, has won the Platinum award at the 2025 Pinnacle Awards, highlighting its status as a category benchmark in the gaming industry [1][2] - The game is recognized for its strong intellectual property foundation, advanced production pipeline, and innovative take on Wuxia culture, marking a significant achievement in the AAA gaming sector [2] Company Overview - CreateAI is a global applied artificial intelligence company with a focus on digital entertainment, operating in the US, China, and Japan [5] - The company aims to redefine digital storytelling through the integration of generative AI technology and creative talent, enhancing the immersive experience for global audiences [5] Product Details - Heroes of Jin Yong is built using Unreal Engine 5 and features a large-scale open world of 960 square kilometers, recreating characters and locations from 15 classic Wuxia novels [3] - The game emphasizes player freedom, diverse gameplay systems, and rich storytelling, aiming to deliver a cinematic and immersive experience [3] Strategic Importance - Heroes of Jin Yong is a high-investment strategic project for CreateAI, alongside the global IP The Three-Body Problem, forming the core of the company's content portfolio [4] - The company is committed to promoting Chinese culture globally and leveraging technological advancements to enhance its storytelling capabilities [4]

See if any of these high-yield stocks are worth buying.The Nasdaq stock exchange isn't known for dividend stocks. It's more associated with tech stocks, which don't generally pay dividends until they've reached maturity, and even then, they tend to be small.However, there are still some Nasdaq stocks to offer strong dividends. Using the Nasdaq-100 index of the 100 largest Nasdaq stocks to simplify things, here are the top three dividend payers in the index. 1. Kraft Heinz (dividend yield: 6.5%)Packaged food ...

Market Analysis by covering: Accenture plc. Read 's Market Analysis on Investing.com ...

Lamb Weston Holdings, Inc. (NYSE:LW) will release earnings results for its second quarter before the opening bell on Friday, Dec. 19.Analysts expect the Eagle, Idaho-based company to report quarterly earnings at 65 cents per share, down from 66 cents per share in the year-ago period. The consensus estimate for Lamb Weston's quarterly revenue is $1.59 billion. Last year, it reported $1.6 billion in revenue, according to Benzinga Pro.On Sept. 30, Lamb Weston posted first-quarter fiscal 2026 net sales of $1.66 ...

Core Insights - Lamb Weston Holdings, Inc. is set to release its second-quarter earnings results on December 19, with analysts expecting earnings of 65 cents per share, a slight decrease from 66 cents per share in the same period last year [1] - The consensus estimate for quarterly revenue is $1.59 billion, down from $1.6 billion reported last year [1] Financial Performance - For the first quarter of fiscal 2026, Lamb Weston reported net sales of $1.66 billion, a slight increase from $1.65 billion a year earlier and exceeding the estimate of $1.62 billion [2] - Shares of Lamb Weston closed at $59.33, reflecting a 0.2% decline [2] Analyst Ratings - B of A Securities analyst maintained a Neutral rating and raised the price target from $60 to $66 [4] - Stifel analyst maintained a Hold rating and reduced the price target from $63 to $56 [4] - Jefferies analyst maintained a Buy rating but lowered the price target from $80 to $75 [4] - Barclays analyst maintained an Overweight rating and cut the price target from $87 to $69 [4]

Company Overview - Guerbet is a global leader in medical imaging, offering a comprehensive range of pharmaceutical products, medical devices, and digital and AI solutions for diagnostic and interventional imaging [5] - The company has been a pioneer in contrast agents for 98 years and employs 2,905 people worldwide [6] - Guerbet dedicated 9% of its revenue to Research & Development across four centers in France and the United States [6] - In 2024, Guerbet achieved €841 million in revenue [6] Appointment of François Convenant - François Convenant has been appointed as Senior Vice President of Interventional Radiology and will join the Guerbet Group's Executive Committee [1] - He joined Guerbet in September 2018 and has extensive international experience in the healthcare and medical device sector [2] - His previous roles involved management positions at leading companies, focusing on innovation and growth in surgical solutions and interventional devices [2] Interventional Radiology Insights - Interventional radiology is a rapidly expanding medical specialty that combines advanced imaging with minimally invasive therapeutic procedures [3] - This field is experiencing rapid growth due to an aging population and increasing demand for less invasive treatments [3] - Technological innovations, including AI, robotics, and precision imaging, are enhancing the safety and effectiveness of procedures [3] - The economic and clinical impact includes reduced costs related to complications and improved quality of life for patients [4] Guerbet's Mission and Offerings - Guerbet aims to meet the needs of healthcare institutions and practitioners by providing integrated and innovative solutions [4] - The company combines drugs, medical devices, services, and technologies, supported by dedicated training programs to enhance clinical practices [4]